In February, Takeda signed an MoU on rare diseases with the Medical Services Administration under the Ministry of Health, in ...

Access to innovation is proving increasingly difficult for UK cancer patients. Unpicking the policy barriers is important for ...

Please find enclosed copy of the Unaudited Financial Results for the quarter and nine months ended 30th September 2024.

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...

The Sanofi deal helps shed significant costs every year and will bring in cash through royalties. The partnership also allows ...

View the full release here: "We are honored to be recognized with the Prix Galien Award for Best Digital Health Solution," ...